Durability of Immunogenicity at 5 Years after a Single Dose of Human Papillomavirus Vaccine Compared with Two Doses in Tanzanian Girls Aged 9-14 Years: Results of the Long-Term Extension of the DoRIS Randomised Trial.
The Lancet Global health（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined